TY - JOUR
T1 - S100P
T2 - A novel therapeutic target for cancer
AU - Arumugam, Thiruvengadam
AU - Logsdon, Craig D.
N1 - Funding Information:
This work was supported in part by the Marc Rich Foundation, the M.D. Anderson Support Core grant CA16672, the M.D. Anderson Pancreatic Specialized Programs of Research Excellence (SPORE) grant P20 CA101936, the Lockton Endowment and by Public Health Service Grant DK56338, which funds the Texas Medical Center Digestive Diseases Center.
PY - 2011/10
Y1 - 2011/10
N2 - S100P expression is described in many different cancers, and its expression is associated with drug resistance, metastasis, and poor clinical outcome. S100P is member of the S100 family of small calcium-binding proteins that have been reported to have either intracellular or extracellular functions, or both. Extracellular S100P can bind with the receptor for advanced glycation end products (RAGE) and activate cellular signaling. Through RAGE, S100P has been shown to mediate tumor growth, drug resistance, and metastasis. S100P is specifically expressed in cancer cells in the adult. Therefore, S100P is a useful marker for differentiating cancer cells from normal cells, and can aid in the diagnosis of cancer by cytological examination. The expression of S100P in cancer cells has been related to hypomethylation of the gene. Multiple studies have confirmed the beneficial effects of blocking S100P/RAGE in cancer cells, and different blockers are being developed including small molecules and antagonist peptides. This review summarizes the role and significance of S100P in different cancers.
AB - S100P expression is described in many different cancers, and its expression is associated with drug resistance, metastasis, and poor clinical outcome. S100P is member of the S100 family of small calcium-binding proteins that have been reported to have either intracellular or extracellular functions, or both. Extracellular S100P can bind with the receptor for advanced glycation end products (RAGE) and activate cellular signaling. Through RAGE, S100P has been shown to mediate tumor growth, drug resistance, and metastasis. S100P is specifically expressed in cancer cells in the adult. Therefore, S100P is a useful marker for differentiating cancer cells from normal cells, and can aid in the diagnosis of cancer by cytological examination. The expression of S100P in cancer cells has been related to hypomethylation of the gene. Multiple studies have confirmed the beneficial effects of blocking S100P/RAGE in cancer cells, and different blockers are being developed including small molecules and antagonist peptides. This review summarizes the role and significance of S100P in different cancers.
KW - Calcium-binding protein
KW - Cancer
KW - Cromolyn
KW - RAGE
KW - S100P
UR - http://www.scopus.com/inward/record.url?scp=83255187667&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=83255187667&partnerID=8YFLogxK
U2 - 10.1007/s00726-010-0496-4
DO - 10.1007/s00726-010-0496-4
M3 - Review article
C2 - 20509035
AN - SCOPUS:83255187667
SN - 0939-4451
VL - 41
SP - 893
EP - 899
JO - Amino Acids
JF - Amino Acids
IS - 4
ER -